Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: The 10-year follow-up of the belfast diet study

Diabetic Medicine

Volumn 15, Issue 4, 1998, Pages 290-296

  Levy, J ^a,b   Atkinson, A B ^b   Bell, P M ^a   McCance, D R ^b   Hadden, D R ^a  

^a Diabetes Research Laboratories   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Beta cell function; Diet therapy; HOMA analysis; Insulin sensitivity; Plasma glucose control

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; METFORMIN; TOLBUTAMIDE;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DETERIORATION; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; WEIGHT REDUCTION;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MALE; METFORMIN; MIDDLE AGED; NORTHERN IRELAND; TIME FACTORS; TOLBUTAMIDE; TREATMENT FAILURE;

EID: 0031961242     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M     Document Type: Article

References (18)

1. Hadden DR, Patterson CC, Atkinson AB, Kennedy L, Bell PM, McCance DR, Weaver JA. Macrovascular disease and hyperglycaemia. 10 year survival analysis in Type 2 diabetes: the Belfast diet study. Diabetic Med 1997 14, 663-672.
2. Madden DR, Montgomery DAD, Skelly RJ, Trimble ER, Weaver JA, Wilson EA, et al. Maturity onset diabetes mellitus: response to intensive dietary therapy. Br Med J 1975; 2: 276-278.
3. Wilson EA, Madden DR, Montgomery DAD, Weaver JA. Dietary management of maturity onset diabetes. Br Med 71980; 3: 1367-1369.
4. University Group Diabetes Program. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes: II. Mortality results. Diabetes 1970; 19 (suppl 2): 785-830.
5. Madden DR, Blair AL, Wilson EA, Boyle DM, Atkinson AB, Kennedy AL, et al. Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy. Q J Med 1986; 59: 579-598.
6. Rudenski AS, Madden DR, Atkinson AB, Kennedy L, Matthews DR, Merrett JD, et al. Natural history of pancreatic islet β-cell function in Type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabetic Med 1988; 5: 36-41.
7. Hadden DR, Wilson EA. Dietary management of diabetes mellitus. Proc Nutr Soc 1981; 40; 247-255.
8. Society of Actuaries. Build and Blood Pressure Study, vol. 1. Chicago: Society of Actuaries, 1959: 16.
9. Holmes J, Hadden DR, Atkinson AB, Kennedy AL, Wilson EA. Assessment of diet adherence in relation to long-term follow up of non-insulin-dependent diabetics. Practical Diabetes 1987; 4: 276-278.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28:412-419.
11. Hermans M, Coppack S, Levy J. Comparison of 4 in vivo insulin sensitivity tests to discriminate between individuals over the range of glucose tolerance by assessment of their discriminant ratio. Diabetes 1995; 44 (suppl 1):200A.
12. Levy J, Manley S, Sutton P, Camps I. Beta-cell function assessed by the hyperglycaemic clamp: reproducibility compared with HOMA analysis from fasting values, and factors influencing variability. Diabetes 1995; 44 (suppl 1): 89A.
13. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44-49.
14. Walshe K, Andrews WJ, Sheridan B, Woods R, Madden DR. Three months energy restricted diet does not reduce peripheral insulin resistance in newly diagnosed non insulin dependent diabetics. Horm Melabol Res 1987; 19: 197-200.
15. Hosker JP, Kumar S, Gordon C, Bhatnagar D, France M, Boulton AJ. Diet treatment of newly presenting type 2 diabetes improves insulin secretory capacity, but has no effect on insulin sensitivity. Diabetic Med 1993; 10: 509-513.
16. Turner RC, Cull CA, Stratton IM, Manley SE, Kohner EM, Matthews DR, et al. United Kingdom Prospective Study (UKPDS) .16: Overview of 6 years' therapy of Type 2 diabetes: a progressive disease. Diabetes 1995; 44: 1249-1256.
17. Madden DR, Montgomery DAD, Weaver JA. Long-term experience with chlorpropamide in diabetes mellitus. Diabetes 1962; 11: 91-95.
18. Madden DR, Montgomery DAD, Weaver JA. Secondary failure to sulphonylurea treatment. Irish J Med Sei 1963; 132: 469-474.